FELICE; Philip V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for FELICE; Philip V..The latest application filed is for "platform drug delivery system utilizing crystal engineering and theanine dissolution".

Company Profile

1.13.22

FELICE; Philip V. - Smithtown NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Platform Drug Delivery System Utilizing Crystal Engineering And Theanine Dissolution App 20210177758 - BRITTAIN; Harry G. ; et al.	2021-06-17
Sublingual Formulation With Water-soluble Cocrystals Of Acetylsalicylic Acid With Citric Acid, Sodium Bicarbonate, And L-theanin App 20200101010 - FELICE; Philip V. ; et al.	2020-04-02
Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine Grant 10,376,464 - Brittain , et al. A	2019-08-13
Platform Drug Delivery System Utilizing Crystal Engineering And Theanine Dissolution App 20180064649 - BRITTAIN; Harry G. ; et al.	2018-03-08
Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine Grant 9,896,411 - Brittain , et al. February 20, 2	2018-02-20
Characterization Of The Cocrystal Products Formed By Metoprolol And Dabigatran Bases With L-theanine App 20170143648 - Brittain; Harry G. ; et al.	2017-05-25
Characterization Of The Cocrystal Products Formed By Metoprolol And Dabigatran Bases With L-theanine App 20170143838 - BRITTAIN; HARRY G. ; et al.	2017-05-25
Characterization Of The Cocrystal Products Formed By Metoprolol And Dabigatran Bases With L-theanine App 20170144964 - Brittain; Harry G. ; et al.	2017-05-25
Platform drug delivery system utilizing crystal engineering and theanine dissolution Grant 9,603,937 - Brittain , et al. March 28, 2	2017-03-28
Platform drug delivery system utilizing crystal engineering and theanine dissolution Grant 9,603,938 - Brittain , et al. March 28, 2	2017-03-28
Platform drug delivery system utilizing crystal engineering and theanine dissolution Grant 9,603,939 - Brittain , et al. March 28, 2	2017-03-28
Platform Drug Delivery System Utilizing Crystal Engineering And Theanine Dissolution App 20160263138 - BRITTAIN; HARRY G. ; et al.	2016-09-15
Platform Drug Delivery System Utilizing Crystal Engineering And Theanine Dissolution App 20160263224 - Brittain; Harry G. ; et al.	2016-09-15
Platform Drug Delivery System Utilizing Crystal Engineering And Theanine Dissolution App 20160263229 - BRITTAIN; HARRY G. ; et al.	2016-09-15
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Grant 9,289,439 - Brittain , et al. March 22, 2	2016-03-22
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Grant 9,289,440 - Brittain , et al. March 22, 2	2016-03-22
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Grant 9,289,438 - Brittain , et al. March 22, 2	2016-03-22
Adjuvant To Thrombolytic Therapy For The Treatment Of Frostbite App 20140343021 - Brittain; Harry G. ; et al.	2014-11-20
Intravenous Formulation With Water-soluble Cocrystals Of Acetylsalicylic Acid And Theanine App 20140296189 - Brittain; Harry G. ; et al.	2014-10-02
Intravenous Formulation With Water-soluble Cocrystals Of Acetylsalicylic Acid And Theanine App 20140288029 - Brittain; Harry G. ; et al.	2014-09-25
Intravenous Formulation With Water-soluble Cocrystals Of Acetylsalicylic Acid And Theanine App 20140179644 - Brittain; Harry G. ; et al.	2014-06-26
Intravenous Formulation With Water-soluble Cocrystals Of Acetylsalicylic Acid And Theanine App 20140148418 - Brittain; Harry G. ; et al.	2014-05-29
Intravenous Formulation With Water-soluble Cocrystals Of Acetylsalicylic Acid And Theanine App 20130345183 - Brittain; Harry G. ; et al.	2013-12-26
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Grant 8,476,250 - Brittain , et al. July 2, 2	2013-07-02
Intravenous Formulation with Water-soluble CoCrystals of Acetylsalicylic Acid and Theanine App 20130123218 - BRITTAIN; Harry ; et al.	2013-05-16
Intravenous Formulation With Water-soluble Cocrystals Of Acetylsalicylic Acid And Theanine App 20130012482 - Brittain; Harry G. ; et al.	2013-01-10
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Grant 8,304,404 - Brittain , et al. November 6, 2	2012-11-06
Intravenous Formulation with Water-Soluble CoCrystals of Acetylsalicylic Acid and Theanine App 20120190655 - Brittain; Harry G. ; et al.	2012-07-26
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine Grant 8,173,625 - Brittain , et al. May 8, 2	2012-05-08
Intravenous Formulation With Water-soluble Cocrystals Of Acetylsalicylic Acid And Theanine App 20100286099 - Brittain; Harry G. ; et al.	2010-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.